Get the Stockscreener App
92.94
0.67%
0.62
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $92.94, with a volume of 5.25M.
It is up +0.67% in the last 24 hours and up +8.11% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$92.32
Open:
$91.965
24h Volume:
5.25M
Relative Volume:
0.69
Market Cap:
$119.08B
Revenue:
$33.54B
Net Income/Loss:
$4.66B
P/E Ratio:
25.67
EPS:
3.62
Net Cash Flow:
$5.19B
1W Performance:
+3.72%
1M Performance:
+8.11%
6M Performance:
+3.05%
1Y Performance:
+18.46%
1-Day Range:
$91.93
$93.10
1-Week Range:
$89.18
$93.10
52-Week Range:
$78.32
$96.25
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
92.94 | 118.29B | 33.54B | 4.66B | 5.19B | 3.62 |
|
ABT
Abbott Laboratories
|
126.54 | 218.59B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.14 | 157.13B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
403.53 | 151.59B | 23.22B | 2.86B | 3.58B | 7.40 |
|
EW
Edwards Lifesciences Corp
|
80.00 | 44.46B | 5.69B | 4.15B | 623.10M | 6.95 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-30-25 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-16-25 | Initiated | Leerink Partners | Outperform |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
What institutional investors are buying Medtronic plc stockBreakthrough stock performance - jammulinksnews.com
Medtronic plc (MDT): A Bull Case Theory - MSN
What analysts say about Medtronic plc stockHigh-yield trading alerts - PrintWeekIndia
Medtronic takes next step to submit bone graft for new FDA indication - MassDevice
Telemetric Devices Market Set to Witness Significant Growth - openPR.com
Here's What to Expect From Medtronic's Next Earnings Report - MSN
U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott - Yahoo Finance
Medtronic's Fiscal Q1 2026 Earnings Preview: What to ExpectNews and Statistics - IndexBox
Here's What To Expect From Medtronic's Next Earnings Report - Barchart.com
Medtronic receives Type 2 label expansion for MiniMed 780G in Europe - MedTech Dive
Medtronic plc (NYSE:MDT) is largely controlled by institutional shareholders who own 87% of the company - simplywall.st
Insulin Pumps Market Outlook Report 2025, with Leading Player Profiles for Medtronic, Insulet, Tandem Diabetes Care, and More - Yahoo.co
What drives Medtronic plc stock priceDynamic profit opportunities - Autocar Professional
Medtronic plc Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional
Is Medtronic plc a good long term investmentMarket-crushing profits - jammulinksnews.com
Medtronic (MDT) Outpaces Stock Market Gains: What You Should Know - Nasdaq
Medtronic gets EU nod for MiniMed 780G System - MSN
Medtronic’s (MDT) Role in Medical Devices: A Unique Fit for Halal Portfolios - MSN
Medtronic (MDT): A Shariah-Compliant Powerhouse in the Evolving Medical Device Sector - AInvest
Medtronic's Unique Fit for Halal Portfolios: A Surgeon's Sense of Purpose and Accuracy - AInvest
Medtronic MiniMed 780G wins CE mark for type 2 diabetes, young children - MassDevice
Court Nixes Jury Award Over Medtronic's Heart Valve Infringement ClaimMedtronic (NYSE:MDT) - Benzinga
Medtronic gets EU nod for MiniMed 780G System (MDT:NYSE) - Seeking Alpha
Medtronic (MDT) Expands MiniMed 780G System Indications with Eur - GuruFocus
Medtronic expands MiniMed 780G system indications across Europe - Investing.com Australia
Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes - Medtronic
10 Magnificent S&P 500 Dividend Stocks Down Over 10% to Buy and Hold Forever - The Motley Fool
Medtronic wins appeals to avoid $106.5M patent verdict - MSN
Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict - MassDevice
Fed. Circ. Frees Medtronic From $125M Patent Judgment - Law360
Medtronic wins appeal to avoid $106.5M patent verdict (MDT:NYSE) - Seeking Alpha
Medtronic wins US appeal to overturn $106.5 mln heart-valve patent verdict - Reuters
Breaking Barriers: Medtronic and Zverev Unite - Il Messaggero
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.73%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):